UM  > 健康科學學院
ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors
Godefridus J. Peters1; Kin Tam2
2016
Source PublicationADMET & DMPK
ISSN1848-7718
Volume4Issue:3Pages:182-185
DOIhttp://doi.org/doi:10.5599/admet.4.3.348
Indexed BySCI
Language英语
WOS Research AreaPharmacology & Pharmacy
WOS SubjectPharmacology & Pharmacy
WOS IDWOS:000447338500001
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionFaculty of Health Sciences
Corresponding AuthorGodefridus J. Peters; Kin Tam
Affiliation1.Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands
2.Faculty of Health Sciences, University of Macau, Taipa, Macau
Corresponding Author AffilicationFaculty of Health Sciences
Recommended Citation
GB/T 7714
Godefridus J. Peters,Kin Tam. ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors[J]. ADMET & DMPK,2016,4(3):182-185.
APA Godefridus J. Peters,&Kin Tam.(2016).ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors.ADMET & DMPK,4(3),182-185.
MLA Godefridus J. Peters,et al."ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors".ADMET & DMPK 4.3(2016):182-185.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Godefridus J. Peters]'s Articles
[Kin Tam]'s Articles
Baidu academic
Similar articles in Baidu academic
[Godefridus J. Peters]'s Articles
[Kin Tam]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Godefridus J. Peters]'s Articles
[Kin Tam]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.